News und Analysen
Granite Announces Fourth Quarter and Year End Results for 2022 and Provides Development Update
Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three month period and year ended
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head
Sumitomo Heavy Industries, Ltd. invests in Alpha Fusion Inc., developer of Astatine based radiopharmaceuticals for Targeted Alpha Therapy
Sumitomo Heavy Industries, Ltd. (“SHI”) (TOKYO:6302) (Head Office: Shinagawa-ku, Tokyo, President and CEO: Shinji Shimomura) announced the decision to invest in Alpha Fusion Inc. (“AF”) (Head
EQS-News: BP p.l.c.: Director Declaration
EQS-News: BP p.l.c.: Director Declaration
Fujitec Co., Ltd.: Notice Concerning the Board of Directors’ Position on the Agenda Item to be Submitted by the Company and Agenda Items Proposed by a Shareholder for the Upcoming Extraordinary General Meeting of the Shareholders
Fujitec Co., Ltd. (TOKYO:6406):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230206005725/en/
Fujitec Co., Ltd. (Photo: Business
Azbil Launches New Sapphire Capacitance Diaphragm Gauges with MEMS Processing Technology to Enhance Resistance to Deposition
Azbil Corporation (TOKYO:6845) announced the availability as of January 25 of its model V8 sapphire capacitance diaphragm gauges, which employ MEMS*1 processing technology to enhance resistance to
Azbil Launches New Sapphire Capacitance Diaphragm Gauges with MEMS Processing Technology to Enhance Resistance to Deposition
Azbil Corporation (TOKYO:6845) announced the availability as of January 25 of its model V8 sapphire capacitance diaphragm gauges, which employ MEMS*1 processing technology to enhance resistance to
Azbil Launches New Sapphire Capacitance Diaphragm Gauges with MEMS Processing Technology to Enhance Resistance to Deposition
Azbil Corporation (TOKYO:6845) announced the availability as of January 25 of its model V8 sapphire capacitance diaphragm gauges, which employ MEMS*1 processing technology to enhance resistance to
GLORY Announces Latest Back Office Retail Cash Recycling Solution CI-100X
Glory [TYO: 6457], a global leader in cash technology solutions, today announces the launch of the latest solution in their next generation market-leading CASHINFINITY™ retail cash recycling
GLORY Announces Latest Back Office Retail Cash Recycling Solution CI-100X
Glory [TYO: 6457], a global leader in cash technology solutions, today announces the launch of the latest solution in their next generation market-leading CASHINFINITY™ retail cash recycling
GLORY Announces Latest Back Office Retail Cash Recycling Solution CI-100X
Glory [TYO: 6457], a global leader in cash technology solutions, today announces the launch of the latest solution in their next generation market-leading CASHINFINITY™ retail cash recycling
Toyota Boshoku to Exhibit at CES 2023
Toyota Boshoku Corporation will exhibit at CES 2023 to be held in Las Vegas, Nevada, USA from January 5th (Thursday) to January 8th (Sunday), 2023
We have created new values as the "Interior Space
Toyota Boshoku to Exhibit at CES 2023
Toyota Boshoku Corporation will exhibit at CES 2023 to be held in Las Vegas, Nevada, USA from January 5th (Thursday) to January 8th (Sunday), 2023
We have created new values as the "Interior Space
Toyota Boshoku to Exhibit at CES 2023
Toyota Boshoku Corporation will exhibit at CES 2023 to be held in Las Vegas, Nevada, USA from January 5th (Thursday) to January 8th (Sunday), 2023
We have created new values as the "Interior Space
GenSight Biologics Announces Publication of Indirect Comparison of LUMEVOQ® Versus Natural History in ND4-LHON Patients in Peer-Reviewed Journal Ophthalmology and Therapy
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221214006010/en/
Figure 1: from Indirect Comparison of Lenadogene
CORRECTING and REPLACING CI Global Asset Management Announces Estimated Annual Reinvested Capital Gains Distributions for CI ETFs
Please replace the release dated December 8, 2022 with the following corrected version due to additional amendments to the estimated annual reinvested capital gains for CI Gold Bullion Fund.
The
SHI receives first order for next-generation proton therapy system from Taichung Veterans General Hospital
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter "SHI") has received an order from Taichung Veterans General
SHI receives first order for next-generation proton therapy system from Taichung Veterans General Hospital
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter "SHI") has received an order from Taichung Veterans General
SHI receives first order for next-generation proton therapy system from Taichung Veterans General Hospital
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter "SHI") has received an order from Taichung Veterans General
SHI receives first order for next-generation proton therapy system from Taichung Veterans General Hospital
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter "SHI") has received an order from Taichung Veterans General
SHI receives first order for next-generation proton therapy system from Taichung Veterans General Hospital
Sumitomo Heavy Industries, Ltd. (TOKYO:6302) (head office: Shinagawa City, Tokyo; President and CEO: Shinji Shimomura; hereinafter "SHI") has received an order from Taichung Veterans General